The rise, fall, and resurgence of immunotherapy in type 1 diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Moufida,Ben Nasr ^[1] ; Francesca,D'Addio ^[1] ; Vera,Usuelli ^[2] ; Sara,Tezza ^[1] ; Reza,Abdi ^[3] ; Paolo,Fiorina ^[4]

作者单位： Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; IRCCS, Ospedale San Raffaele, Milan, Italy. ^[1] IRCCS, Ospedale San Raffaele, Milan, Italy. ^[2] Transplantation Research Center, Nephrology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[3] Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; IRCCS, Ospedale San Raffaele, Milan, Italy. Electronic address: paolo.fiorina@childrens.harvard.edu. ^[4]

关键词 B cells Hematopoietic stem cells Immunosuppression Immunotherapy NOD mice T cells Type 1 diabetes

主题词动物(Animals);临床试验(主题)(Clinical Trials as Topic);糖尿病, 1型(Diabetes Mellitus, Type 1);药物评价, 临床前(Drug Evaluation, Preclinical);人类(Humans);免疫疗法(Immunotherapy)

DOI 10.1016/j.phrs.2014.07.004

PMID 25107501

发布时间 2015-06-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交